Ad

Second U.S. study for COVID-19 vaccine uses skin-deep shots

WASHINGTON – U.S. researchers have opened another safety test of an experimental COVID-19 vaccine, this one using a skin-deep shot instead of the usual deeper jab. The pinch shoul...

Virus is mostly mild and rarely fatal for U.S. kids, data show

The first national data on COVID-19 in U.S. children suggest that while the illness usually isn’t severe in kids, some do get sick enough to require hospital treatment. The Center...

What to know about malaria drug and coronavirus treatment

Some politicians and doctors are sparring over whether to use hydroxychloroquine against the new coronavirus, with many of scientists saying the evidence is too thin to recommend it now. ...

No COVID-19 testing at home yet but quicker options coming

WASHINGTON – Home testing for the new coronavirus may sound like a good idea, but U.S. regulators say it’s still too risky. They’ve stopped companies that quickly launched home-te...

Age is not the only risk for severe coronavirus disease

WASHINGTON – Older people remain most at risk of dying as the new coronavirus continues its rampage around the globe, but they’re far from the only ones vulnerable. One of many mysteries: Me...

How would overwhelmed hospitals decide who to treat first?

NEW YORK – A nurse with asthma, a grandfather with cancer and a homeless man with no known family are wracked with coronavirus-induced fevers. They are struggling to breathe, and a ventilato...

For seniors, isolation changes life in varied, nuanced ways

One remembers the polio epidemic and the hardships of World War II. One is stoic about it all – because, he says, he’s already “here past the welcome.” A third, old enough to remember the af...

For nursing homes, symptoms aren’t enough to tell who’s sick

SEATTLE – An investigation at a Seattle-area nursing home concluded that symptoms aren’t enough to identify who is infected once the coronavirus enters a long-term care facility. ...

They already had an anxiety disorder. Now comes a pandemic.

NEW YORK – At first, Jonathon Seidl wasn’t worried about the coronavirus despite his anxiety disorder. But that changed. The 33-year-old digital media strategist from Dallas, who ...

Drugmaker backpedals on specialty status for COVID-19 drug

WASHINGTON – Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition ...

Can blood from coronavirus survivors treat the newly ill?

WASHINGTON – Hospitals are gearing up to test if a century-old treatment used to fight off flu and measles outbreaks in the days before vaccines, and tried more recently against SARS and Ebo...

Potential coronavirus treatment granted rare disease status

WASHINGTON – The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth milli...